Loading...
CareDx, Inc
CDNA•NASDAQ
Healthcare
Medical - Diagnostics & Research
$12.79
$-0.05(-0.39%)
CareDx, Inc (CDNA) Financial Performance & Income Statement Overview
Review CareDx, Inc’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
19.07%
↑ 19.07%
Operating Income Growth
120.05%
↑ 120.05%
Net Income Growth
127.62%
↑ 127.62%
Operating Cash Flow Growth
306.92%
↑ 306.92%
Operating Margin
13.51%
↑ 13.51%
Gross Margin
67.46%
↑ 67.46%
Net Profit Margin
16.99%
↑ 16.99%
ROE
18.17%
↑ 18.17%
ROIC
11.57%
↑ 11.57%
CareDx, Inc (CDNA) Income Statement & Financial Overview
Review CareDx, Inc's (CDNA) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $86.58M | $82.88M | $92.27M | $72.05M |
| Cost of Revenue | $28.18M | $27.57M | $28.57M | $26.57M |
| Gross Profit | $58.40M | $55.31M | $63.70M | $45.48M |
| Gross Profit Ratio | $0.67 | $0.67 | $0.69 | $0.63 |
| R&D Expenses | $16.53M | $17.49M | $19.68M | $18.71M |
| SG&A Expenses | $61.76M | $48.32M | $48.05M | $46.11M |
| Operating Expenses | -$16.29M | $65.80M | $67.73M | $64.82M |
| Total Costs & Expenses | $11.89M | $93.38M | $96.30M | $91.39M |
| Interest Income | $3.05M | $3.001M | $2.83M | $2.88M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $4.69M | $4.89M | $4.96M | $5.22M |
| EBITDA | $84.38M | -$5.60M | $927000.00 | -$14.11M |
| EBITDA Ratio | $0.97 | -$0.07 | $0.01 | -$0.20 |
| Operating Income | $74.69M | -$10.49M | -$4.03M | -$19.34M |
| Operating Income Ratio | $0.86 | -$0.13 | -$0.04 | -$0.27 |
| Other Income/Expenses (Net) | $13.18M | $3.28M | $2.73M | $2.60M |
| Income Before Tax | $87.87M | -$7.21M | -$1.37M | -$16.74M |
| Income Before Tax Ratio | $1.01 | -$0.09 | -$0.01 | -$0.23 |
| Income Tax Expense | -$171000.00 | $200000.00 | $22000.00 | -$83000.00 |
| Net Income | $78.01M | -$7.41M | -$1.39M | -$16.66M |
| Net Income Ratio | $0.90 | -$0.09 | -$0.02 | -$0.23 |
| EPS | $1.62 | -$0.14 | -$0.03 | -$0.32 |
| Diluted EPS | $1.51 | -$0.14 | -$0.03 | -$0.32 |
| Weighted Avg Shares Outstanding | $54.28M | $52.90M | $52.20M | $51.69M |
| Weighted Avg Shares Outstanding (Diluted) | $58.22M | $52.90M | $52.20M | $51.69M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan